Descrizione del progetto
L’etica nell’era del progresso tecnologico: rivolgere l’attenzione alla medicina della riproduzione femminile
La medicina della riproduzione riguarda tutti gli aspetti della vita umana dalla fecondazione fino al parto e affronta i problemi nel concepimento naturale attraverso trattamenti medicalmente assistiti. In un’era in cui le tecnologie sono in rapida evoluzione, l’obiettivo principale del progetto ERIN, finanziato dall’UE, è portare nelle cliniche innovazioni più responsabili sotto il profilo etico, in pratiche quali la conservazione della fertilità in donne a rischio e lo svolgimento di analisi genetiche dell’embrione. I partner del progetto affronteranno tutte le potenziali preoccupazioni etiche, i rischi e le vulnerabilità legati a soluzioni di procreazione innovative, preparando il terreno per pratiche eticamente responsabili. Inoltre, assicureranno parità di accesso alla medicina della riproduzione alle donne vulnerabili in attesa del parto.
Obiettivo
ERIN project was initiated to spread the academic excellence to University of Tartu (UT) in Estonia as representative of the Widening country, by enhancing networking activities with internationally-leading counterparts, Karolinska Institute (Sweden) and Maastricht University Medical Centre (The Netherlands).
The consortium increases the scientific, innovation and clinical superbness of UT and its partners, by raising the R&I profiles, and the proficiency to identify, explore and resolve the ethical challenges in female reproductive medicine. We deal with the most intimate aspects of human life, by medically assisting conception, by carrying out a genetic analysis of an embryo or fetus to have a healthy baby, and by preserving fertility in women whose fertility is at risk. In the era of rapidly progressing technologies, novel solutions emerge fasten than the conclusive clinical evidence is collected and ethical challenges are addressed. Reproductive medicine is also often unsatisfactorily publicly supported, creating an inequality in access for the most vulnerable category of the patients, women waiting for childbirth.
This is why reproductive medicine, covering human life from fertilization till birth, requires special attention to tackle all possible ethical concerns, risks and vulnerabilities, and involving all stakeholders, from individual patients to broad community. By addressing these challenges, we aim to bring more ethically responsible innovations into clinic that do not harm the interests of the various stakeholders, are evidence-based, cost-effective and therefore could be implemented in a sustainable way to ensure that these novel solutions become widely accessible.
As an outcome, ERIN improves the responsible innovation practices, establish ethical system in R&I, expands knowledge and innovation capacity of the UT, and improves proficiency of all partners to facilitate the equity of access to research advances in reproductive medicine.
Campo scientifico
Parole chiave
Programma(i)
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-WIDESPREAD-2020-5
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
51005 Tartu
Estonia